The Scientist

» prison, cell & molecular biology and culture

Most Recent

image: Designer Aspirin Fights Cancer

Designer Aspirin Fights Cancer

By | March 5, 2012

Early experiments show that a hybrid form of the common pain reliever can effectively inhibit the growth of many tumor types.

0 Comments

In Chapter 8, "The Conspiratorial Move and the Struggle for Evidence-Based Medicine," author Nicoli Natrass explores the Internet's role in the rise of anti-science sentiment.

12 Comments

image: Capsule Reviews

Capsule Reviews

By | March 1, 2012

The Wandering Gene and the Indian Princess, The Forever Fix, Connectome, and DNA USA

4 Comments

image: David Sabatini: Demystifying mTOR

David Sabatini: Demystifying mTOR

By | March 1, 2012

Principal Investigator, Whitehead Institute for Biomedical Research. Associate Professor, Department of Biology, Massachusetts Institute of Technology. Age: 44

0 Comments

image: Delivering Silence

Delivering Silence

By | March 1, 2012

Using RNA viruses to silence genes could optimize tissue targeting while reducing toxicity.

0 Comments

image: Speaking of Science

Speaking of Science

By | March 1, 2012

March 2012's selection of notable quotes

6 Comments

image: Electron Microscopy Through the Ages

Electron Microscopy Through the Ages

By | March 1, 2012

Take a tour through the revolutionary menthod's past, present, and future.

8 Comments

image: Promoting Death

Promoting Death

By | March 1, 2012

Editor's choice in biochemistry

0 Comments

image: The Specter of Denialism

The Specter of Denialism

By | March 1, 2012

Conspiracy theories surrounding the global HIV/AIDS epidemic have cost thousands of lives. But science is fighting back.

94 Comments

image: The Subcellular World Revealed, 1945

The Subcellular World Revealed, 1945

By | March 1, 2012

The first electron microscope to peer into an intact cell ushers in the new field of cell biology.

4 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham